Ashish Gupta

Title: Ashish Gupta: Innovator in RNA-Programmable Endonuclease Systems

Introduction

Ashish Gupta is a prominent inventor based in Leverkusen, Germany. He has made significant contributions to the field of genetic engineering, particularly in the development of RNA-programmable endonuclease systems. With a total of 2 patents, Gupta's work is at the forefront of innovative technologies aimed at manipulating DNA within cells.

Latest Patents

Gupta's latest patents include groundbreaking inventions related to RNA-programmable endonuclease systems. The first patent focuses on novel systems for targeting, editing, or manipulating DNA in a cell using synthetic RNA-guided nucleases (sRGNs) derived from wildtype or parental small type II CRISPR Cas9 endonucleases. The second patent also addresses RNA-programmable endonuclease systems, detailing their use in genome editing and other applications. This invention comprises one or more heterologous vectors encoding a SluCas9 nuclease and guide RNAs (gRNAs), showcasing Gupta's innovative approach to genetic manipulation.

Career Highlights

Throughout his career, Ashish Gupta has worked with notable companies such as Bayer Healthcare LLC and Crispr Therapeutics AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research and development.

Collaborations

Gupta has collaborated with talented individuals, including Andre Cohnen and Moritz Schmidt. These partnerships have further enhanced his work and have been instrumental in advancing the technologies he has developed.

Conclusion

Ashish Gupta's contributions to RNA-programmable endonuclease systems represent a significant advancement in genetic engineering. His innovative patents and collaborations with leading companies and experts highlight his role as a key figure in this evolving field.